Saudi VC Prosperity7 led investment of $14 million in Chinese firm

Prosperity7 Ventures, the venture fund of Saudi Aramco Ventures, has led a $14 million investment in Shenzhen Cispoly Bio-Tec, a Chinese developer of women's health screening tools.

Established in 2020 in Beijing, Cispoly focuses on improving women's health by detecting gynecological tumors early. They have special technology for cervical, ovarian, and endometrial cancers. The company is known for its research, development, and sales of automated testing equipment. (Prosperity7 serves as the diversified growth fund under Aramco Ventures, a subsidiary of Aramco, the Saudi energy and chemicals company. With a $1 billion venture capital fund, Prosperity7 adopts a global investment strategy across all sectors.)

Prosperity7 Ventures is listed in the Middle East Investors Directory with the code BJ96.